former Chief Scientific Officer (7) · Coherus Oncology, Inc. (CHRS)

Vladimir Vexler

A named executive officer of Coherus Oncology in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,148,650

Salary $182,829Stock awards $360,800

FY2022: $2,152,185

3rd of 5 named executive officers at Coherus Oncology by FY2023 total.

5 named officers on file for Coherus Oncology, FY2023

Vladimir Vexler’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 28 equity grants, each cited to its filing
  • CHRS’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Coherus Oncology’s whole pay program stands against its peers

  • Coherus Oncology’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CHRS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 15, 2024 (DEF 14A).

Free

Get Vladimir Vexler’s full pay file as a PDF — free

More than this page: up to 10 years of Vladimir’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Vladimir Vexler compensation by year

Coherus Oncology Summary Compensation Table · all 6 fiscal years held
In US dollars, as Coherus Oncology reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021FY2022FY2023
Salary$393,083$447,525$480,704$508,877$537,575$182,829
Bonus$6,874$58,282$0$0$0$0
Stock awards$0$0$554,063$844,575$637,600$360,800
Option awards$769,578$993,208$681,769$1,173,834$734,824$767,252
Non-equity incentive$185,628$257,326$287,455$269,407$234,686$0
Pension and deferred compensation$0$0$0$0$0$0
All other$0$888$308$0$7,500$837,769
Total$1,355,163$1,757,229$2,004,299$2,796,693$2,152,185$2,148,650

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Coherus Oncology, Inc. DEF 14A filed April 15, 2024, accession 0001558370-24-005131, and prior-year filings.

How this page was built: the Coherus Oncology, Inc. filed document, accession 0001558370-24-005131. Every figure is read from that document and cited to the page and table it appears in. Filed April 15, 2024.

$1.4M
$1.8M
$2.0M
$2.8M
$2.2M
$2.1M
FY18
FY19
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Coherus Oncology’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Dennis LanfearPresident, Chief Executive Officer and Chairman of the Board of Directors$5,897,924
McDavid Stilwellformer Chief Financial Officer (6)$2,304,733
Vladimir Vexler · this pageformer Chief Scientific Officer (7)$2,148,650
Paul ReiderChief Commercial Officer$1,930,559
Bryan McMichaelInterim Chief Financial Officer (5)$1,070,218

The full Coherus Oncology compensation record

free company brief

This page is one person within Coherus Oncology's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Coherus Oncology proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Coherus Oncology's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Vladimir Vexler's compensation dossier · One-time report. No refunds.